CBG

Cannabigerol

C₂₁H₃₂O₂ 316.48 g/mol Non-intoxicating

Typical abundanceminor

Receptor targets

α2-adrenoceptor (agonist) · 5-HT1A (antagonist) · CB1/CB2 (weak)

Mechanism of action

Derived from its acidic precursor CBGA. Engages α2-adrenergic and serotonin receptors and binds the cannabinoid receptors only weakly.

Reported effects

Anti-inflammatory (preclinical)Neuroprotective (preclinical)

Common terpenes

Limonene Pinene Caryophyllene

Research

Largely preclinical; anti-inflammatory and neuroprotective activity reported in laboratory models, with human evidence still limited.